The London COPD Exacerbation Cohort (EXCEL_Cohort)

Imperial College London

Status: Enrolling

Conditions: Pulmonary Disease, Chronic Obstructive

Study type: Observational

Funder types: Other

Identifiers

NCT02755974

14IC1925

Details and patient eligibility

About

The London COPD exacerbation (EXCEL) cohort builds on an established cohort started in 1995 and designed to study COPD exacerbations and their impact on health-status and disease progression.

Full description

Our intentions are to phenotype Chronic Obstructive Pulmonary Disease (COPD) patients on the basis of factors that a related to (a) exacerbation frequency which will include (b) lung function to assess disease severity, (c) baseline therapy, (d) airway and systemic inflammatory markers, (e) health status, (f) gene expression, (g) airway bacterial and viral load and (h) co-morbidity including cardiovascular disease, diabetes and psychological disease, (i) psychological factors,(j) mortality, (k) nasal susceptibility to rhinovirus infection, (l) heart rate variability (m) exhaled hydrogen sulphide.

Enrollment: 300 estimated patients

Sex: All

Ages: 40 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Forced Expiratory Volume in 1 sec (FEV1)/Forced Vital Capacity (FVC) ratio of <0.70
• Able and willing to give informed and written consent

Exclusion criteria

• Patients with a history of asthma, bronchiectasis, carcinoma of the bronchus, or other significant respiratory disease were excluded.
• Patients on Immunosuppressive medications or with active cancer
• Long term steroid therapy
• Age <40 years at recruitment